ViroGates Management
Jakob Knudsen, Chief Executive Officer
Jakob assumed his role as CEO in April 2011.
Jakob was previously CCO & CFO of Egalet Ltd. a Danish based biotech company focusing on development of pain products. Jakob oversaw all commercial operations including IP and Financing and was responsible for entering into 8 commercial collaborations (licensing and feasibility stage agreements). In addition Jakob closed several rounds of financing and also the transition of the business from a Danish legal entity into the UK legal entity. Prior to this Jakob was heading the Corporate Business Development function at ALK-Abelló A/S, a Danish biopharmaceutical company. Jakob was responsible for ALK’s deals for its allergy tablet portfolio and over his 9 year tenure, was involved with ALK’s acquisitions made over the years with target companies in Switzerland, France, New York and a joint venture in Germany.
Jakob was responsible for setting up ALK-Abelló’s Chinese subsidiary and he also took part in the processes to independently list ALK on the Copenhagen Stock Exchange. Jakob has additionally held responsibility for various sales and marketing functions.
Jakob is a lawyer by training and trained with the law-firm Arup & Hvidt in Copenhagen. He also holds an MBA from Imperial College, UK.
May Britt Dyvelkov, Chief Financial Officer
May assumed her role as CFO in November 2008.
May Britt Dyvelkov have been working in finance her entire career. She has been in leading financial positions for several IT companies, most recently as CFO of the Icelandic IT reseller Kerfi A/S (since 2001). Prior to joining Kerfi she held the position of CFO in EET Nordic for 6 years. May has been creating financial systems and implemented them to fit companies growing from 7 to 70 employees, and has been part of several mergers and acquisition.
Claus Berner, VP Sales & Marketing
Claus assumed his role as Vice President of Sales & Marketing in November 2008.
Claus has worked within the Life Science sector his entire career; most recently he held the position of Global Marketing Director at US based Hollister Inc., providing leadership to the global ostomy business in the areas of new product development, business development and global marketing. Prior to joining Hollister, he served with Danish Blood Gas pioneer Radiometer Medical A/S in key international marketing positions in Denmark, the UK and Spain.
Claus holds a M.Sc. in Economics from Copenhagen Business School (CBS), Denmark (1985) and participates actively in various network groups within biotechnology, marketing and management development.
